Evaluation of invasive breast cancer samples using a 12-chemokine gene expression score: correlation with clinical outcomes von Prabhakaran, Sangeetha, Rizk, Victoria T, Ma, Zhenjun, Cheng, Chia-Ho, Berglund, Anders E, Coppola, Dominico, Khalil, Farah, Mulé, James J, Soliman, Hatem H

Volltext

Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+breast cancer brain metastases von Mills, Matthew N., Walker, Chelsea, Thawani, Chetna, Naz, Afrin, Figura, Nicholas B., Kushchayev, Sergiy, Etame, Arnold, Yu, Hsiang-Hsuan Michael, Robinson, Timothy J., Liu, James, Vogelbaum, Michael A., Forsyth, Peter A., Czerniecki, Brian J., Soliman, Hatem H., Han, Hyo S., Ahmed, Kamran A.

Volltext

nab -Paclitaxel as a potential partner with checkpoint inhibitors in solid tumors von Soliman, Hatem H

Volltext

Capecitabine and stereotactic radiation in the management of breast cancer brain metastases von Mills, Matthew N., Naz, Afrin, Thawani, Chetna, Walker, Chelsea, Figura, Nicholas B., Kushchayev, Sergiy, Oliver, Daniel E., Etame, Arnold B., Yu, Hsiang-Hsuan Michael, Robinson, Timothy J., Liu, James K. C., Vogelbaum, Michael A., Forsyth, Peter A., Czerniecki, Brian J., Soliman, Hatem H., Han, Hyo S., Ahmed, Kamran A.

Volltext

Real‐world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropenia von Sun, James, Zhong, Xiaojun, Ma, Junjie, Sun, Weihong, Han, Hyo S., Soliman, Hatem H., Loftus, Loretta S., Costa, Ricardo L. B., Armaghani, Avan J., Soyano‐Muller, Aixa E., Czerniecki, Brian J., Lee, M. Catherine, Kiluk, John V., Khakpour, Nazanin, Hoover, Susan J., Laronga, Christine, Khong, Hung T.

Volltext

Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastases von Khatri, Vaseem M., Mestres-Villanueva, Mariella A., Yarlagadda, Sreenija, Doniparthi, Ajay, Smith, David B., Nakashima, Justyn Y., Bryant, John M., Zhao, Dekuang, Upadhyay, Rituraj, Mills, Matthew N., Oliver, Daniel E., Yu, Hsiang-Hsuan Michael, Palmer, Joshua D., Williams, Nicole O., Mahtani, Reshma L., Ahluwalia, Manmeet S., Soliman, Hatem H., Han, Hyo S., Soyano, Aixa E., Kim, Youngchul, Kotecha, Rupesh, Beyer, Sasha J., Ahmed, Kamran A.

Volltext

Open-label, Phase I Study of Nivolumab Combined with nab-Paclitaxel Plus Gemcitabine in Advanced Pancreatic Cancer von Wainberg, Zev A., Hochster, Howard S., Kim, Edward J., George, Ben, Kaylan, Aparna, Chiorean, E. Gabriela, Waterhouse, David M., Guiterrez, Martin, Parikh, Aparna, Jain, Rishi, Carrizosa, Daniel Ricardo, Soliman, Hatem H., Lila, Thomas, Reiss, David J., Pierce, Daniel W., Bhore, Rafia, Banerjee, Sibabrata, Lyons, Larry, Louis, Chrystal U., Ong, Teng Jin, O'Dwyer, Peter J.

Volltext

Emerging immunotherapeutic strategies for the treatment of breast cancer von Huppert, Laura A., Mariotti, Veronica, Chien, A. Jo, Soliman, Hatem H.

Volltext

Nivolumab and Stereotactic Radiosurgery for Patients With Breast Cancer Brain Metastases: A Nonrandomized, Open-Label Phase 1b Study von Ahmed, Kamran A., Kim, Youngchul, Arrington, John A., Kim, Sungjune, DeJesus, Michelle, Soyano, Aixa E., Armaghani, Avan J., Costa, Ricardo L.B., Khong, Hung T., Loftus, Loretta S., Rosa, Marilin, Caudell, Jimmy J., Diaz, Roberto, Robinson, Timothy J., Etame, Arnold B., Tran, Nam D., Sahebjam, Solmaz, Soliman, Hatem H., Czerniecki, Brian J., Forsyth, Peter A., Yu, H. Michael, Han, Hyo S.

Volltext

A phase I study of indoximod in patients with advanced malignancies von Soliman, Hatem H, Minton, Susan E, Han, Hyo Sook, Ismail-Khan, Roohi, Neuger, Anthony, Khambati, Fatema, Noyes, David, Lush, Richard, Chiappori, Alberto A, Roberts, John D, Link, Charles, Vahanian, Nicholas N, Mautino, Mario, Streicher, Howard, Sullivan, Daniel M, Antonia, Scott J

Volltext

A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors von Soliman, Hatem H, Jackson, Erica, Neuger, Tony, Dees, E Claire, Harvey, R Donald, Han, Hyo, Ismail-Khan, Roohi, Minton, Susan, Vahanian, Nicholas N, Link, Charles, Sullivan, Daniel M, Antonia, Scott

Volltext

Personalizing Radiation Treatment Delivery in the Management of Breast Cancer von Diaz, Roberto, Torres-Roca, Javier F., Han, Hyo S., Soliman, Hatem H., Montejo, Michael E., Liveringhouse, Casey, Orman, Amber G., Grass, G. Daniel, Ahmed, Kamran A., Czerniecki, Brian J.

Volltext

Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastases von Khatri, Vaseem M., Mills, Matthew N., Oliver, Daniel E., Yu, Hsiang-Hsuan Michael, Vogelbaum, Michael A., Forsyth, Peter A., Soliman, Hatem H., Han, Hyo S., Ahmed, Kamran A.

Volltext

Single drug biomarker prediction for ER− breast cancer outcome from chemotherapy von Chen, Yong-Zi, Kim, Youngchul, Soliman, Hatem H, Ying, GuoGuang, Lee, Jae K

Volltext

The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs von Mills, Matthew N., Potluri, Thrisha K., Kawahara, Yuki, Fahey, Matthew, Figura, Nicholas B., Soyano, Aixa E., Washington, Iman R., Diaz, Roberto, Oliver, Daniel E., Yu, Hsiang-Hsuan Michael, Etame, Arnold B., Vogelbaum, Michael A., Czerniecki, Brian J., Arrington, John A., Sahebjam, Solmaz, Forsyth, Peter A., Soliman, Hatem H., Han, Hyo S., Ahmed, Kamran A.

Volltext

Breast cancer subtype predicts clinical outcomes after stereotactic radiation for brain metastases von Mills, Matthew N., Thawani, Chetna, Figura, Nicholas B., Oliver, Daniel E., Soyano, Aixa E., Etame, Arnold, Robinson, Timothy J., Liu, James K., Vogelbaum, Michael A., Forsyth, Peter A., Czerniecki, Brian J., Soliman, Hatem H., Han, Hyo S., Yu, Hsiang-Hsuan Michael, Ahmed, Kamran A.

Volltext

Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer von Creelan, Ben C., Antonia, Scott J, Bepler, Gerold, Garrett, Timothy J., Simon, George R., Soliman, Hatem H.

Volltext

Replicative Instability Drives Cancer Progression von Morris, Benjamin B, Smith, Jason P, Zhang, Qi, Jiang, Zhijie, Hampton, Oliver A, Churchman, Michelle L, Arnold, Susanne M, Owen, Dwight H, Gray, Jhanelle E, Dillon, Patrick M, Soliman, Hatem H, Stover, Daniel G, Colman, Howard, Chakravarti, Arnab, Shain, Kenneth H, Silva, Ariosto S, Villano, John L, Vogelbaum, Michael A, Borges, Virginia F, Akerley, Wallace L, Gentzler, Ryan D, Hall, Richard D, Matsen, Cindy B, Ulrich, C M, Post, Andrew R, Nix, David A, Singer, Eric A, Larner, James M, Stukenberg, Peter Todd, Jones, David R, Mayo, Marty W

Volltext

Abstract PS7-69: Molecular profiles and clinical-pathological features of Asian early-stage breast cancer patients von Chen, Margaret, Kwong, Ava, Hendricks, Carolyn, D'Abreo, Nina, Lee, Laura, Soliman, Hatem H., Cox, Charles, Kling, Heather M., Bhaskaran, Rajith, Wang, Shiyu, Menicucci, Andrea, Untch, Sarah, Audeh, William

Volltext

Abstract OT2-09-01: Phase I/II study of stereotactic radiation and abemaciclib in the management of hormone receptor positive HER2 negative breast cancer brain metastases von Ahmed, Kamran A., Kim, Youngchul, DeJesus, Michelle, Beyer, Sasha J., Williams, Nicole O., Palmer, Joshua, Woodhouse, Kristina D., Murthy, Rashmi K., Li, Jing, Armaghani, Avan J., Arrington, John A., Costa, Ricardo L., Czerniecki, Brian J., Etame, Arnold B., Forsyth, Peter A., Khong, Hung T., Oliver, Daniel E., Rosa, Marilin, Sahebjam, Solmaz, Soliman, Hatem H., Soyano, Aixa E., Vogelbaum, Michael A., Yu, Michael, Han, Hyo S.

Volltext